StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.61−0.19 (-3.96%)

Close on Nov 17, 2026Market cap $57.89MP/E –Yield –

Neuraxis EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Neuraxis's EPS for the twelve months ending Jun 30, 2026 was -$0.79. For fiscal 2025 it was -$0.95.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.95–
FY2024Dec 31, 2024-$1.22–
FY2023Dec 31, 2023-$4.50–
FY2022Dec 31, 2022-$2.77–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.19–
Q1 FY2026Mar 31, 2026-$0.18–
Q4 FY2025Dec 31, 2025-$0.18–
Q3 FY2025Sep 30, 2025-$0.24–
Q2 FY2025Jun 30, 2025-$0.22–
Q1 FY2025Mar 31, 2025-$0.33–
Q4 FY2024Dec 31, 2024-$0.22–
Q3 FY2024Sep 30, 2024-$0.25–
Q2 FY2024Jun 30, 2024-$0.42–
Q1 FY2024Mar 31, 2024-$0.32–
Q4 FY2023Dec 31, 2023-$0.30–
Q3 FY2023Sep 30, 2023-$2.38–
Q2 FY2023Jun 30, 2023-$1.21–
Q1 FY2023Mar 31, 2023-$1.18–
Q4 FY2022Dec 31, 2022-$0.10–
Q3 FY2022Sep 30, 2022-$1.14–
Q2 FY2022Jun 30, 2022-$0.87–

More Neuraxis figures

See a number that looks wrong?